Nasdaq-listed Galecto has completed the acquisition of Damora Therapeutics. Galecto, founded in 2011 by leading galectin scientists and biotech executives from Sweden, the UK, and Denmark, develops small molecules for the…
US: Galecto acquires Damora Tx and raises US$285m from Series C
…
…






